MARÍA DE LOS-ÁNGELES ALLER REYERO-rekin lankidetzan egindako argitalpenak (39)

2019

  1. Mast cell-mediated splanchnic cholestatic inflammation

    Clinics and Research in Hepatology and Gastroenterology, Vol. 43, Núm. 5, pp. 561-574

2013

  1. Experimental Models of Surgical Inflammation

    Surgical Inflammation (Bentham), pp. 309-343

  2. Splanchnic-aortic inflammatory axis in experimental portal hypertension

    World Journal of Gastroenterology, Vol. 19, Núm. 44, pp. 7992-7999

2012

  1. Effect of short- and long-term portal hypertension on adrenergic, nitrergic and sensory functioning in rat mesenteric artery

    Clinical Science, Vol. 122, Núm. 7, pp. 337-348

2011

  1. Gut-brain chemokine changes in portal hypertensive rats

    Digestive Diseases and Sciences, Vol. 56, Núm. 8, pp. 2309-2317

2010

  1. Bacterial translocation to mesenteric lymph nodes increases in chronic portal hypertensive rats

    Digestive Diseases and Sciences, Vol. 55, Núm. 8, pp. 2244-2254

  2. Partial hepatectomy, partial portal vein stenosis and mesenteric lymphadenectomy increase splanchnic mast cell infiltration in the rat

    Acta Histochemica, Vol. 112, Núm. 4, pp. 372-382

2009

  1. Anesthesia, analgesia and postoperative care

    Microsurgery in Liver Research (Bentham Science Publishers Ltd.), pp. 49-70

  2. Extraction techniques of blood, bile and lymph samples

    Microsurgery in Liver Research (Bentham Science Publishers Ltd.), pp. 71-93

  3. Laboratory rat management

    Microsurgery in Liver Research (Bentham Science Publishers Ltd.), pp. 7-31

  4. Portal surgery: Portosystemic shunts and portal hypertension

    Microsurgery in Liver Research (Bentham Science Publishers Ltd.), pp. 117-136

  5. The value of microsurgery in liver research

    Liver International, Vol. 29, Núm. 8, pp. 1132-1140

2008

  1. Chronic prehepatic portal hypertension in the rat: Is it a type of Metabolic Inflammatory Syndrome?

    Lipids in Health and Disease, Vol. 7

  2. Mast cell inhibition by ketotifen reduces splanchnic inflammatory response in a portal hypertension model in rats

    Experimental and Toxicologic Pathology, Vol. 60, Núm. 4-5, pp. 347-355

2007

  1. Evolutive phases of experimental prehepatic portal hypertension

    Journal of Gastroenterology and Hepatology (Australia), Vol. 22, Núm. 7, pp. 1127-1133

  2. Partial portal vein ligation plus thioacetamide: A method to obtain a new model of cirrhosis and chronic portal hypertension in the rat

    Journal of Gastrointestinal Surgery, Vol. 11, Núm. 2, pp. 187-194

2006

  1. Hepatic lipid metabolism changes in short- and long-term prehepatic portal hypertensive rats

    World Journal of Gastroenterology, Vol. 12, Núm. 42, pp. 6828-6834

  2. Prehepatic portal hypertension induces alterations in cytochrome oxidase activity in the rat adrenal gland

    Journal of Investigative Surgery, Vol. 19, Núm. 2, pp. 79-86

2005

  1. Evaluation of two experimental models of hepatic encephalopathy in rats

    Brazilian Journal of Medical and Biological Research, Vol. 38, Núm. 1, pp. 127-132

  2. Increased cytochrome oxidase activity in adrenal glands of thioacetamide-cirrhotic rats

    Neuroendocrinology Letters, Vol. 26, Núm. 6, pp. 719-723